Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer

PSA-TRICOM (PROSTVAC) is a novel vector-based vaccine designed to generate a robust immune response against prostate-specific antigen (PSA)–expressing tumor cells. The purpose of this report is to present an overview of both published studies and new data in the evaluation of immune responses to the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gulley, James L., Madan, Ravi A., Tsang, Kwong Y., Jochems, Caroline, Marté, Jennifer L., Farsaci, Benedetto, Tucker, Jo A., Hodge, James W., Liewehr, David J., Steinberg, Seth M., Heery, Christopher R., Schlom, Jeffrey
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004961/
https://ncbi.nlm.nih.gov/pubmed/24778277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-13-0108
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares